🎤 Join our founder group to hear from firms like NEA on What it takes to raise a Series A?

Register
Shahin Farshchi

Shahin Farshchi

Partner·Lux Capital

Bio

Professional summary

Shahin Farshchi is a Partner at Lux Capital who has spent more than two decades partnering with founders building frontier technologies. He joined Lux in 2006 after founding a company based on his PhD research designing chips, systems, and software to capture and interpret brain signals. Lux says he has co-founded and led investments across AI, semiconductors, autonomy, and aerospace, including companies that became public or were acquired by Intel, Amazon, Silicon Labs, and Lattice Semiconductor.

Notable companies

Selected portfolio companies the partner has backed

AevaPlanet LabsNervanaZooxSilicon ClocksSiBeam

Background

Career, education, and skills

Career history

  • Lux CapitalPartner2006 – Present
  • PhD research-based brain-signal technology companyFounder2004
  • Software startupsStartup roles

Education

  • University not publicly specified in cited sourcePhD

Other partners at Lux Capital

12 more profiles

Bilal Zuberi

Bilal Zuberi

Co-President & General Partner

Lux Capital

Bilal Zuberi is associated with Lux Capital as a long-time deeptech investor. Public profiles describe more than a decade as a Lux General Partner, with investments across applied AI, autonomy, industrial technology, hardware, climate, healthcare and other technically ambitious sectors.

DeeptechHardwareIndustrial AI
Brandon Reeves

Brandon Reeves

Partner

Lux Capital

Lux partner investing in AI, software, defense, manufacturing and robotics.

Artificial intelligenceAutonomous systemsDefenseManufacturingRoboticsSoftware
Danny Crichton

Danny Crichton

Partner, Research

Lux Capital

Lux Partner, Research and editor-in-chief, formerly managing editor at TechCrunch.

FinanceMediaResearchRiskgamingScienceTechnology analysis
David K. Yang

David K. Yang

Partner

Lux Capital

Lux life sciences partner focused on therapeutics, R&D tools and biopharma infrastructure.

Biopharma infrastructureBiotechLife sciencesR&D toolsTherapeutics
DS

Deena Shakir

Partner

Lux Capital

Deena Shakir is a Partner at Lux Capital. Her official profile says she invests across stages and sectors, including women's health, digital health infrastructure, health equity, foodtech, and fintech.

Digital health infrastructureFintechFoodtechWomen's health
Firas Atwa

Firas Atwa

Lux Capital

Harvard MBA candidate with prior Algebra Ventures, Swvl, and Alvarez & Marsal experience.

AfricaEmerging marketsEntrepreneurshipFintechStrategyVenture capital
Grace Isford

Grace Isford

Partner

Lux Capital

Lux partner investing in computational sciences, AI applications, and infrastructure software.

AIComputational sciencesInfrastructure softwareLLM applicationsPhysical-world software
Josh Wolfe

Josh Wolfe

Partner and Co-Founder

Lux Capital

Josh Wolfe is Partner and Co-Founder at Lux Capital. His official profile says he helps lead the firm, invests in defense and biotech, and has co-founded more than 20 Lux companies.

AIBiotechRoboticsSpace
Lan Jiang

Lan Jiang

Partner

Lux Capital

Lux partner focused on biotech analytics, ML infrastructure, developer tooling, and AI applications.

AI applicationsBiotech analyticsDeveloper toolingHealthcareMachine learning infrastructurePlatform therapeutics
Laurence Pevsner

Laurence Pevsner

Partner, Research

Lux Capital

Lux research partner focused on media, pedagogy, Riskgaming, and science-policy communication.

Editorial partnershipsPublic policyResearchRiskgamingScience communicationStrategic messaging
Peter Hébert

Peter Hébert

Partner and Co-Founder

Lux Capital

Peter Hébert is Partner and Co-Founder at Lux Capital. His official profile says he helps lead the firm, invests across technology and healthcare, and launched Lux's Health + Tech investment strategy.

DeeptechFrontier technology
RP

Robert Paull

Co-Founder and Venture Partner

Lux Capital

Lux co-founder and healthcare venture partner with biotech CEO and company-formation experience.

BiotechHealthcareHealthcare ITInfectious diseaseNeurotechnologyOphthalmology